Back to search

Article

Genetic alteration of ferredoxin NADP <sup>+</sup> -reductase or cysteine desulfurase in piperaquine-resistant <i>Plasmodium berghei</i> restores susceptibility to lumefantrine and abolishes the impact of probenecid, verapamil, and cyproheptadine

2019-11-06

Abstract excerpt

Chemotherapy remains central in the control of malaria; however, resistance has consistently thwarted these efforts. Currently, lumefantrine (LM), and piperaquine (PQ) drugs, are essential components in the mainstay artemisinin-based therapies used for the treatment of malaria globally. Using LM and PQ-resistant Plasmodium berghei , we measured the effect of known chemosensitizers: probenecid, verapamil, or cypro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
10c2a8ff-4202-5587-8c6c-8fc165c89c24
DOI
10.1101/833145
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genetic alteration of ferredoxin NADP <sup>+</sup> -reductase or cysteine desulfurase in piperaquine-resistant <i>Plasmodium berghei</i> restores susceptibility to lumefantrine and abolishes the impact of probenecid, verapamil, and cyproheptadineDOI 10.1101/833145
Select a neighboring publication to make it the new centre.